Role of Serum Dipeptidyle Peptidase IV (DDP IV) Activity in Development of Non – Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease

Journal Title: International Journal of Medical Research Professionals - Year 2018, Vol 4, Issue 5

Abstract

Background: Nonalcoholic fatty liver disease (NAFLD) is defined as the abnormal accumulation of lipids, primarily in the form of triglycerides in individuals who do not consume significant amounts of alcohol (≤ 20 g ethanol/d). It is characterized by a spectrum of disease varying from simple steatosis through to steatohepatitis with fibrosis and scarring, which can lead to cirrhosis. Dipeptidyl peptidase-4 (DPP4), also known as adenosine deaminase complexing protein 2 or CD26 (cluster of differentiation 26) is a protein that, in humans, is encoded by the DPP4 gene. Aim of the work: To study the role of serum dipeptidyle peptidase IV activity in development and progression of simple steatosis to non-alcoholic steatohepatitis in patients with non-alcoholic fatty liver disease and its role in follow up the progression to chronic liver disease. Methods: This study was conducted as a case-control study in Internal Medicine Department of Ain Shams University Hospital and included 30 patients with non-alcoholic fatty liver (group I) and 30 patients with non-alcoholic steatohepatitis (group II) , 30 healthy individuals were taken as a control group (III). All cases are subjected to full history clinical examination full Lab., abdominal sonar and assessment of (DDP IV, CD26). Results: It is suggested that circulating DDP4 may play a role in the progression of non – alcoholic fatty liver disease (NAFLD) to non – alcoholic steatohepatitis because of its ability to differentiate simple steatosis from steatohepatitis. Conclusion: When NAFLD is induced by nutritional overload, hepatic inflammation enhances hepatic DPP4 expression. Accelerated degradation of GLP-1 by DPP4 inhibits insulin secretion and causes hyperglycemia. Hyperglycemia further enhances DPP4 expression, with further worsening in glucose metabolism. The increased hepatic expression of DPP4 in NAFLD patients suggests that DPP4 may be involved in the onset and/or progression of NAFLD. Hepatic inflammation may induce this phenomenon, although DPP4 causes deteriorations in systemic glucose metabolism.

Authors and Affiliations

Khaled Abd Elhamed Mohammed, Inas El Khedr Mohammed, Hany Haroun Kaiser, Khaled Rafik Elbaz, Hesham Drwesh

Keywords

Related Articles

Bilateral Percutaneous Nephrolithotomy in Single Session in Children Under General Anaesthesia: Our Experience

Objective: To evaluate the efficacy of removing bilateral kidney stones simultaneously from children, in one session. Patients and Methods: Thirteen patients (three girls and 10 boys, 26 kidneys; mean age 8 years, range...

Bacteriological Profile and Antibiogram of Burn Wound Infections from Burn Patients at RIMS, Ranchi

Introduction: Burn wounds are especially prone to infection which is a major cause of morbidity and mortality in hospitalised burn patients. Identification of bacterial isolates from specimens of burn patients and study...

Evaluation of Microbial Profile of Patients with Post-Traumatic Endophthalmitis: An Institutional based Study

Background: Post-traumatic infectious endophthalmitis is an uncommon but severe complication of ocular trauma. Polymicrobial infections in such cases are very common, but species of Staphylococcus and Bacillus are the co...

Assessment of Prevalence of Anaemia among Rural Population: An Observational Institutional Based Study

Background: Anemia is a commonly encountered medical condition affecting a major proportion of rural population. In an individual patient it may be that some decline in haemoglobin occurs as part of normal ageing, but th...

Risk factors and Outcome of Neonatal Admission to Neonatal Intensive Care Unit in Governmental and Private Hospitals, Al-Madinah Al-Monawarah 2015

Introduction: Various risk factors had been established to be associated with neonatal admission to the intensive care units. These risk factors are laid down in three key groups including maternal factors, fetal and del...

Download PDF file
  • EP ID EP537094
  • DOI 10.21276/ijmrp.2018.4.5.056
  • Views 83
  • Downloads 0

How To Cite

Khaled Abd Elhamed Mohammed, Inas El Khedr Mohammed, Hany Haroun Kaiser, Khaled Rafik Elbaz, Hesham Drwesh (2018). Role of Serum Dipeptidyle Peptidase IV (DDP IV) Activity in Development of Non – Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease. International Journal of Medical Research Professionals, 4(5), 244-252. https://europub.co.uk/articles/-A-537094